日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma

关于新辅助全身治疗后III期黑色素瘤患者行索引淋巴结手术的证据的国际调查

Novis, Elan; Rautalin, Mervi; Amaria, Rodabe N; Ascierto, Paolo A; Blank, Christian U; Faries, Mark B; Grunhagen, Dirk J; Gyorki, David E; Hayes, Andrew J; Kuijpers, Anke M J; Long, Georgina V; Mammen, Joshua M V; Menzies, Alexander M; Ross, Merrick I; Rutkowski, Piotr; Tawbi, Hussein A; Tetzlaff, Michael T; Zager, Jonathan S; Wargo, Jennifer A; Hieken, Tina J; van Akkooi, Alexander C J

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma

长期生存率和生物标志物分析评估新辅助联合辅助治疗瑞拉利单抗(抗LAG3)和纳武利尤单抗(抗PD-1)在可切除黑色素瘤患者中的疗效

Burton, Elizabeth M; Milton, Denái R; Tetzlaff, Michael T; Wani, Khalida; Ross, Merrick I; Postow, Michael A; Lazcano, Rossana; Glitza, Isabella C; Wong, Michael K; Patel, Sapna P; Diab, Adi; Gershenwald, Jeffrey E; McQuade, Jennifer L; Betof Warner, Allison; Prieto, Victor G; Lee, Jeffrey E; Goepfert, Ryan P; Fisher, Sarah B; Song, Addison; Malke, Jared; Simon, Julie M; Ariyan, Charlotte; Torres-Cabala, Carlos A; Davies, Michael A; Lazar, Alexander; Wargo, Jennifer A; Tawbi, Hussein A; Amaria, Rodabe N

Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

附录:多肽疫苗在黑色素瘤辅助治疗中的应用:一项随机 II 期试验的长期生存结果和事后分析

Ninmer, Emily K; Zhu, Hong; Chianese-Bullock, Kimberly A; von Mehren, Margaret; Haas, Naomi B; Ross, Merrick I; Dengel, Lynn T; Slingluff, Craig L Jr

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

转移性黑色素瘤患者的淋巴细胞清除、肿瘤浸润淋巴细胞、高剂量与低剂量IL-2联合帕博利珠单抗治疗

Hasanov, Merve; Kiany, Simin; Forget, Marie-Andrée; Bassett, Roland; Davies, Michael A; Diab, Adi; Gershenwald, Jeffrey E; Glitza, Isabella C; Lee, Jeffrey E; Lucci, Anthony; McQuade, Jennifer L; Patel, Sapna P; Ross, Merrick I; Tawbi, Hussein A; Wargo, Jennifer A; Wong, Michael K; Bernatchez, Chantale; Hwu, Patrick; Haymaker, Cara; Amaria, Rodabe N

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

多肽疫苗在黑色素瘤辅助治疗中的应用:一项随机II期试验的长期生存结果和事后分析

Ninmer, Emily K; Zhu, Hong; Chianese-Bullock, Kimberly A; von Mehren, Margaret; Haas, Naomi B; Ross, Merrick I; Dengel, Lynn T; Slingluff, Craig L Jr

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma

采用低分割放射疗法对不可切除或转移性黑色素瘤实现持久的局部控制

Keatts, Sydney A; Salem, Aya F; Swanson, David M; Farooqi, Ahsan S; Bishop, Andrew J; Amaria, Rodabe N; McQuade, Jennifer L; Glitza Oliva, Isabella C; Diab, Adi; Weiser, Roi; Fisher, Sarah B; Goepfert, Ryan P; Ross, Merrick I; Ashleigh Guadagnolo, B; Mitra, Devarati

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

晚期黑色素瘤的新辅助-辅助或单纯辅助治疗帕博利珠单抗

Patel, Sapna P; Othus, Megan; Chen, Yuanbin; Wright, G Paul Jr; Yost, Kathleen J; Hyngstrom, John R; Hu-Lieskovan, Siwen; Lao, Christopher D; Fecher, Leslie A; Truong, Thach-Giao; Eisenstein, Jennifer L; Chandra, Sunandana; Sosman, Jeffrey A; Kendra, Kari L; Wu, Richard C; Devoe, Craig E; Deutsch, Gary B; Hegde, Aparna; Khalil, Maya; Mangla, Ankit; Reese, Amy M; Ross, Merrick I; Poklepovic, Andrew S; Phan, Giao Q; Onitilo, Adedayo A; Yasar, Demet G; Powers, Benjamin C; Doolittle, Gary C; In, Gino K; Kokot, Niels; Gibney, Geoffrey T; Atkins, Michael B; Shaheen, Montaser; Warneke, James A; Ikeguchi, Alexandra; Najera, Jose E; Chmielowski, Bartosz; Crompton, Joseph G; Floyd, Justin D; Hsueh, Eddy; Margolin, Kim A; Chow, Warren A; Grossmann, Kenneth F; Dietrich, Eliana; Prieto, Victor G; Lowe, Michael C; Buchbinder, Elizabeth I; Kirkwood, John M; Korde, Larissa; Moon, James; Sharon, Elad; Sondak, Vernon K; Ribas, Antoni

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

作者更正:可切除黑色素瘤的新辅助治疗:relatlimab 和 nivolumab

Amaria, Rodabe N; Postow, Michael; Burton, Elizabeth M; Tetzlaff, Michael T; Ross, Merrick I; Torres-Cabala, Carlos; Glitza, Isabella C; Duan, Fei; Milton, Denái R; Busam, Klaus; Simpson, Lauren; McQuade, Jennifer L; Wong, Michael K; Gershenwald, Jeffrey E; Lee, Jeffrey E; Goepfert, Ryan P; Keung, Emily Z; Fisher, Sarah B; Betof-Warner, Allison; Shoushtari, Alexander N; Callahan, Margaret; Coit, Daniel; Bartlett, Edmund K; Bello, Danielle; Momtaz, Parisa; Nicholas, Courtney; Gu, Aidi; Zhang, Xuejun; Korivi, Brinda Rao; Patnana, Madhavi; Patel, Sapna P; Diab, Adi; Lucci, Anthony; Prieto, Victor G; Davies, Michael A; Allison, James P; Sharma, Padmanee; Wargo, Jennifer A; Ariyan, Charlotte; Tawbi, Hussein A

Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical Trial

晚期黑色素瘤新辅助Talimogene Laherparepvec联合手术治疗的5年随访最终结果:一项随机临床试验

Dummer, Reinhard; Gyorki, David E; Hyngstrom, John R; Ning, Meng; Lawrence, Tatiana; Ross, Merrick I

Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma

在III期黑色素瘤患者中,循环肿瘤细胞的存在早于影像学检测到复发。

Lucci, Anthony; Addanki, Sridevi; Chiang, Yi-Ju; Meas, Salyna; Sarli, Vanessa N; Upshaw, Joshua R; Manchem, Mayank; Patel, Sapna P; Wargo, Jennifer A; Gershenwald, Jeffrey E; Ross, Merrick I